Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Samsung Biologics (207940 KS)
Watchlist
304
Analysis
Health Care
•
South Korea
Samsung Biologics Co.,Ltd. manufactures bio-healthcare products. The Company develops, refines, and distributes biopharmaceutical products.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Samsung Biologics
•
05 May 2018 11:59
Samsung BioLogics - Market Sentiment Assessment
The Samsung Biologics Co., Ltd (207940 KS) accounting fraud claim news came out on May 1 (Korea's labor day - statutory holiday). The next three...
Sanghyun Park
Follow
137 Views
Share
bearish
•
Samsung Biologics
•
04 May 2018 22:02
Samsung BioLogics and Biogen: Who Had Control?
The controversy surrounding Samsung Biologics Co., Ltd (207940 KS) 's booking of a fair value gain in 2015 relates to their claim of a "loss of...
Kemp Dolliver, CFA
345 Views
Share
bearish
•
Samsung Biologics
•
01 May 2018 22:55
Samsung Biologics' Accounting Violation's Impact on Samsung C&T and Rest of the Korean Pharmas
On May 1st, 2018, Korea's Financial Supervisory Service (FSS) announced that Samsung Biologics Co., Ltd (207940 KS) violated accounting rules after...
Douglas Kim
Follow
177 Views
Share
bullish
•
Samsung C&T
•
14 Apr 2018 07:37
All Roads Lead to Samsung C&T
The margin of safety in Samsung C&T Corp (028260 KS) has become a lot more attractive versus one or two years ago. In this report, we...
Douglas Kim
Follow
236 Views
Share
bearish
•
Samsung Biologics
•
12 Apr 2018 23:44
A Conversation with Biogen
Biogen Inc (BIIB US) is Samsung Biologics Co., Ltd (207940 KS) 's minority (5.4%) partner in the Samsung Bioepis JV that manufactures and sells...
Kemp Dolliver, CFA
340 Views
Share
First
Previous
45
46
47
48
49
50
51
Next
Last
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.34.5
x